SpyGlass Pharma, Inc. (SGP) Institutional Ownership Changes & 13F Activity
SpyGlass Pharma, Inc. (SGP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Jpmorgan Chase & Co, Geode Capital Management, Llc, Affinity Asset Advisors, Llc, Vanguard Portfolio Management Llc, and Northern Trust Corp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +634 | +5.3% | 12,504 | $278.34K | Q2 2026 | Sep 09, 2026 |
| California State Teachers Retirement System | Buy | +153 | — | 153 | $3.41K | Q2 2026 | Aug 24, 2026 |
| Ameriprise Financial Inc | Buy | +45,668 | — | 45,668 | $1.02M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +38,463 | +8.2% | 507,257 | $11.29M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -30,297 | -4.3% | 674,143 | $15.01M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +26,071 | +43.7% | 85,681 | $1.91M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -16,807 | -60.0% | 11,213 | $249.60K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +9,852 | — | 9,852 | $219.31K | Q2 2026 | Aug 14, 2026 |
| Metlife Investment Management, Llc | Buy | +6,986 | — | 6,986 | $155.51K | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +5,103 | — | 5,103 | $113.59K | Q2 2026 | Aug 14, 2026 |
| Vestal Point Capital, Lp | Buy | +3,240 | +0.5% | 670,000 | $14.91M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +2,069 | +1477.9% | 2,209 | $49.17K | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +1,087 | — | 1,087 | $24.15K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +504 | +592.9% | 589 | $13.00K | Q2 2026 | Aug 14, 2026 |
| Affinity Asset Advisors, Llc | Sell | -118,414 | -47.4% | 131,586 | $2.93M | Q2 2026 | Aug 13, 2026 |
| Vanguard Portfolio Management Llc | Buy | +72,132 | +1960.1% | 75,812 | $1.69M | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +61,589 | +295.2% | 82,451 | $1.84M | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +8,716 | +14.6% | 68,498 | $1.52M | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +7,490 | +1646.2% | 7,945 | $176.86K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Buy | +4,742 | +113.5% | 8,921 | $198.58K | Q2 2026 | Aug 13, 2026 |
| Bnp Paribas Financial Markets | Buy | +2,016 | — | 2,016 | $44.88K | Q2 2026 | Aug 13, 2026 |
| Fmr Llc | Buy | +1,497 | — | 1,497 | $33.32K | Q2 2026 | Aug 13, 2026 |
| Ameritas Investment Partners, Inc. | Buy | +1,006 | — | 1,006 | $22.39K | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Sell | -390 | -0.1% | 434,423 | $9.67M | Q2 2026 | Aug 13, 2026 |
| Vanguard Global Advisers, Llc | Sell | -300 | -6.1% | 4,627 | $103.00K | Q2 2026 | Aug 13, 2026 |
| Jpmorgan Chase & Co | Buy | +629,739 | — | 629,739 | $13.63M | Q2 2026 | Aug 12, 2026 |
| Geode Capital Management, Llc | Buy | +150,785 | +119.2% | 277,325 | $6.18M | Q2 2026 | Aug 12, 2026 |
| Rhumbline Advisers | Buy | +11,844 | — | 11,844 | $263.64K | Q2 2026 | Aug 12, 2026 |
| Virtus Investment Advisers, Llc | Buy | +17,744 | — | 17,744 | $394.98K | Q2 2026 | Aug 11, 2026 |
| Nuveen, Llc | Buy | +14,649 | — | 14,649 | $326.09K | Q2 2026 | Aug 11, 2026 |
Frequently asked questions about SGP activity
Which institutional owners are buying SGP?
Institutional owners buying SGP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in SGP activity?
"Buy" means an investor increased their reported position in SGP compared to the prior reporting period. This reflects growing exposure to SpyGlass Pharma, Inc. (SGP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in SGP increasing?
Institutional interest in SGP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.